111 related articles for article (PubMed ID: 8549329)
1. In vitro activity of MF 5137, a new potent 6-aminoquinolone.
Wise R; Pagella PG; Cecchetti V; Fravolini A; Tabarrini O
Drugs; 1995; 49 Suppl 2():272-3. PubMed ID: 8549329
[No Abstract] [Full Text] [Related]
2. Comparative in vitro activity of BAY Y 3118 with other fluoroquinolones.
Molinari G; Schito GC
Drugs; 1995; 49 Suppl 2():222-5. PubMed ID: 8549310
[No Abstract] [Full Text] [Related]
3. In vitro susceptibility to ciprofloxacin of bacterial strains isolated from chronic otitis media and chronic sinusitis.
Gaillot O; Berche P
Drugs; 1995; 49 Suppl 2():200-2. PubMed ID: 8549303
[No Abstract] [Full Text] [Related]
4. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
[TBL] [Abstract][Full Text] [Related]
5. Comparative activity of three new fluoroquinolones.
Coll R; Esteve M; Moros M; Parés J; Xicota MA
Chemioterapia; 1987 Jun; 6(2 Suppl):152-3. PubMed ID: 3509374
[No Abstract] [Full Text] [Related]
6. Activities of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae.
Dalhoff A
Drugs; 1995; 49 Suppl 2():194-6. PubMed ID: 8549301
[No Abstract] [Full Text] [Related]
7. Lomefloxacin sensitivities.
Smith JM; Hashmi ZS
N Z Med J; 1989 Jul; 102(872):391. PubMed ID: 2797570
[No Abstract] [Full Text] [Related]
8. Lomefloxacin disc susceptibility criteria--a reappraisal.
Smith JM; Hashmi ZS
J Antimicrob Chemother; 1990 Jul; 26(1):152-3. PubMed ID: 2211438
[No Abstract] [Full Text] [Related]
9. In-vitro activity of ciprofloxacin, temafloxacin, azithromycin, clarithromycin and metronidazole against Giardia lamblia.
Ikerd TR; Koletar SL
J Antimicrob Chemother; 1993 Apr; 31(4):615-7. PubMed ID: 8390436
[No Abstract] [Full Text] [Related]
10. Comparative in vitro activity of BAY Y 3118 against selected species.
Verbist L; Verhaegen J
Drugs; 1995; 49 Suppl 2():264-5. PubMed ID: 8549326
[No Abstract] [Full Text] [Related]
11. In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens.
Malmborg AS; Ahlén S
Chemotherapy; 1993; 39(1):32-5. PubMed ID: 8383030
[TBL] [Abstract][Full Text] [Related]
12. The antimicrobial activity of sparfloxacin, a new quinolone.
Paradelis AG; Delidou K; Grigoriadou A; Salpigides G; Pangalis A
Drugs; 1995; 49 Suppl 2():238-9. PubMed ID: 8549316
[No Abstract] [Full Text] [Related]
13. [In vitro evaluation of lomefloxacin].
Dette GA; Knothe H
Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672
[TBL] [Abstract][Full Text] [Related]
14. The in-vitro activity of a new highly active quinolone, DU-6859a.
Jolley A; Andrews JM; Brenwald N; Wise R
J Antimicrob Chemother; 1993 Nov; 32(5):757-63. PubMed ID: 8125840
[No Abstract] [Full Text] [Related]
15. In vitro antibacterial activity of FA103, a new quinolone derivative of C-7 position with 7-perhydrodiazepinone.
Imamori K; Asaoka T; Matsumoto M; Maebashi K; Matsuda H; Tahara Y
Jpn J Antibiot; 1995 Dec; 48(12):1891-8. PubMed ID: 8587163
[TBL] [Abstract][Full Text] [Related]
16. In-vitro activity of OPC-17116 against bacterial enteric pathogens.
Arduino RC; Frosolono M; Murray BE
J Antimicrob Chemother; 1994 Sep; 34(3):403-7. PubMed ID: 7829414
[No Abstract] [Full Text] [Related]
17. In vitro activity of sparfloxacin against selected gram-negative blood culture isolates.
Siristonpun Y; Rojnpisarnvong V; Chongchitmate A; Srimuang S; Tanphaichitra D
Drugs; 1995; 49 Suppl 2():256. PubMed ID: 8549322
[No Abstract] [Full Text] [Related]
18. Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.
Harnett SJ; Fraise AP; Andrews JM; Jevons G; Brenwald NP; Wise R
J Antimicrob Chemother; 2004 May; 53(5):783-92. PubMed ID: 15056651
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of lomefloxacin (NY-198 or SC-47111), a new difluoro-quinolone.
Jones RN
J Chemother; 1989 Jul; 1(4 Suppl):165-7. PubMed ID: 16312353
[No Abstract] [Full Text] [Related]
20. In-vitro activity of OPC-17116 against more than 6000 consecutive clinical isolates: a multicentre international study.
Marco F; Jones RN; Hoban DJ; Pignatari AC; Yamane N; Frei R
J Antimicrob Chemother; 1994 Mar; 33(3):647-54. PubMed ID: 8040130
[No Abstract] [Full Text] [Related]
[Next] [New Search]
